Inhibition of apolipoprotein A-I gene by the aryl hydrocarbon receptor: A potential mechanism for smoking-associated hypoalphalipoproteinemia

Life Sciences

Volumn 91, Issue 1-2, 2012, Pages 64-69

  Naem, Emad ^a   Alcalde, Rosalyn ^a   Gladysz, Margaret ^a   Mesliniene, Sandra ^a   Jaimungal, Sarada ^a   Sheikh Ali, Mae ^a   Haas, Michael J ^a   Wong, Norman C W ^b   Mooradian, Arshag D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Apolipoprotein A I; Aryl hydrocarbon receptor; Dyslipidemia; HDL

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CIGARETTE SMOKE; CYTOCHROME P450 1A1; MESSENGER RNA; NICOTINE; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; CELL CULTURE; CIGARETTE SMOKING; CONTROLLED STUDY; DYSLIPIDEMIA; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOALPHALIPOPROTEINEMIA; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOLIPOPROTEIN A-I; BENZOPYRENES; BLOTTING, WESTERN; CELL LINE; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; HYPOALPHALIPOPROTEINEMIAS; NICOTINE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; RECEPTORS, ARYL HYDROCARBON; SMOKING;

EID: 84863981239     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.06.002     Document Type: Article

References (35)

1. J.A. Ambrose, and R.S. Barua The pathophysiology of cigarette smoking and cardiovascular disease: an update J Am Coll Cardiol 43 2004 1731 1737 (Pubitemid 38622506)
2. S.G. Basci, and O. Hankinson Functional characterization of DNA-binding domains of the subunits of the heterodimeric aryl hydrocarbon receptor complex imputing novel and canonical basic helix-loop-helix protein-DNA interactions J Biol Chem 271 1996 8843 8850 (Pubitemid 26123307)
3. P.A. Bertazzi, D. Consonni, S. Bachetti, M. Rubagotti, A. Baccarelli, and C. Zocchetti Health effects of dioxin exposure: a 20-year mortality study Am J Epidemiol 153 2001 1031 1044 (Pubitemid 32493249)
4. C.S. Brischetto, W.E. Connor, S.L. Connor, and J.D. Matarazzo Plasma lipid and lipoprotein profiles of cigarette smokers from randomly selected families: enhancement of hyperlipidemia and depression of high-density lipoprotein Am J Cardiol 52 1983 675 680 (Pubitemid 13023743)
5. G. Carraro, G. Albertin, M. Forneris, and G.G. Nussdorfer Similar sequence-free amplification of human glyceraldehyde-3-phosphate dehydrogenase for real time RT-PCR applications Mol Cell Probes 19 2005 181 186 (Pubitemid 40432092)
6. Centers for Disease Control and Prevention Annual smoking attributable mortality, years of potential life lost, and economic costs - United States, 1995-1999 MMWR Morb Mortal Wkly Rep 5 1992 300 303
7. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159 (Pubitemid 17064313)
8. M.T. Cooney, A. Dudina, D. De Bacquer, L. Wilhelmsen, S. Sans, and A. Menotti HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk Atherosclerosis 206 2009 611 616
9. P. de Medina, R. Casper, J.F. Savouret, and M. Poirot Synthesis and biological properties of new stilbene derivatives of resveratrol as new selective aryl hydrocarbon modulators J Med Chem 48 2005 287 291 (Pubitemid 40105267)
10. C.M. Gorman, L.F. Moffat, and B.H. Howard Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells Mol Cell Biol 2 1982 1044 1051 (Pubitemid 13227227)
11. M.J. Haas, and A.D. Mooradian Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection Drugs 70 2010 805 821
12. P. Herbomel, B. Bourachot, and M. Yaniv Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma Cell 39 1984 653 662 (Pubitemid 15198603)
13. S. Iwano, F. Asanuma, M. Nukaya, T. Saito, and T. Kamataki CYP1A1-mediated mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons Biochem Biophys Res Commun 337 2005 708 712 (Pubitemid 41429342)
14. H.O. Jauregui, N.T. Hayner, J.L. Driscoll, R. Williams-Holland, M.H. Lipsky, and P.M. Galletti Trypan blue dye uptake and lactate dehydrogenase in adult rat hepatocytes-freshly isolated cells, cell suspensions, and primary monolayer cultures In Vitro 17 1981 1100 1110 (Pubitemid 12119617)
15. M.A. Jonas, J.A. Oates, J.K. Ockene, and C.H. Hennekens Statement on smoking and cardiovascular disease for health care professionals: American Heart Association Circulation 86 1992 1664 1669
16. A.M. Knaapen, D.M. Curfs, D.M. Pachen, R.W. Gottschalk, M.P. de Winther, and M.J. Daemen The environmental carcinogen benzo[a]pyrene induces expression of monocyte-chemoattractant protein-1 in vascular tissue: a possible role in atherogenesis Mutat Res 621 2007 31 41 (Pubitemid 47042068)
17. V. Lecureur, E.L. Ferrec, M. N'diaye, M.L. Vee, C. Gardyn, and D. Gilot ERK-dependent induction of TNF α expression by the environmental contaminant benzo(a)pyrene in primary human macrophages FEBS Lett 579 2005 1904 1910 (Pubitemid 40404029)
18. D.H. Lee, I.K. Lee, K. Song, M. Steffes, W. Toscano, and B.A. Baker A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002 Diabetes Care 29 2006 1638 1644 (Pubitemid 44127593)
19. H.A. Lester, C. Fonck, A.R. Tapper, S. McKinney, M.I. Damaj, and S. Balogh Hypersensitive knockin mouse strains identify receptors and pathways for nicotine action Curr Opin Drug Discov Devel 6 2003 633 639 (Pubitemid 37287932)
20. M. Lyte, and P.H. Bick Modulation of interleukin-1 production by macrophages following benzo(a)pyrene exposure Int J Immunopharmacol 8 1986 377 381 (Pubitemid 16097763)
21. J.E. Michalek, and M. Pavuk Diabetes and cancer in veterans of Operation Ranch Hand after adjustment for calendar period, days of spraying, and time spent in Southeast Asia J Occup Environ Med 50 2008 330 340 (Pubitemid 351365753)
22. M. Navab, S.T. Reddy, B.J. Van Lenten, and A.M. Fogelman HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms Nat Rev Cardiol 8 2011 222 232
23. L.P. Nguyen, and C.A. Bradfield The search for endogenous activators of the aryl hydrocarbon receptor Chem Res Toxicol 21 2008 102 116 (Pubitemid 351219712)
24. C. Parolini, G. Chiesa, Y. Zhu, T. Forte, S. Caligari, and E. Gianazza Targeted replacement of mouse apolipoprotein A-I with human apoA-I or the mutant apoA-IMilano. Evidence of APOA-IM impaired hepatic secretion J Biol Chem 278 2003 4740 4746 (Pubitemid 36800975)
25. X.H. Pei, Y. Nakanishi, H. Inoue, K. Takayama, F. Bai, and N. Hara Polycyclic aromatic hydrocarbons induce IL-8 expression through nuclear factor kappaB activation in A549 cell line Cytokine 19 2002 236 241 (Pubitemid 35257823)
26. N.R. Phillips, R.J. Havel, and J.P. Kane Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides. Association with adiposity and the consumption of ethanol, tobacco, and beverages containing caffeine Arteriosclerosis 1 1981 13 24 (Pubitemid 11062580)
27. N.R. Phillips, R.J. Havel, and J.P. Kane Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables Am J Epidemiol 116 1982 302 313 (Pubitemid 12048410)
28. J.F. Price, P.I. Mowbray, A.J. Lee, A. Rumley, G.D. Lowe, and F.G. Fowkes Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery study Eur Heart J 20 1992 344 353
29. A. Puga, A. Maier, and M. Medvedovic The transcriptional signature of dioxin in human hepatoma HepG2 cells Biochem Pharmacol 60 2000 1129 1142
30. S. Sato, H. Shirakawa, S. Tomita, Y. Ohsaki, K. Haketa, and O. Tooi Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver Toxicol Appl Pharmacol 229 2009 10 19
31. J.D. Smith Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis Curr Opin Investig Drugs 11 2010 989 996
32. Y. Tian, S. Ke, M.S. Denison, A.B. Rabson, and M.A. Gallo Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity J Biol Chem 274 1999 510 515 (Pubitemid 29035090)
33. R.J. Vandebriel, C. Meredith, M.P. Scott, P.J. Roholl, and H. Van Loveren Effects of in vivo exposure to bis(tri-n-butyltin)oxide, hexachlorobenzene, and benzo(a)pyrene on cytokine (receptor) mRNA levels in cultured rat splenocytes and on IL-2 receptor protein levels Toxicol Appl Pharmacol 148 1998 126 136 (Pubitemid 28072784)
34. F. Wang, D. Hoivik, R. Pollenz, and S. Safe Functional and physical interactions between the estrogen receptor, SP1 and nuclear aryl hydrocarbon receptor complexes Nucleic Acids Res 26 1998 3044 3052 (Pubitemid 28297542)
35. D. Wu, N. Nishimura, V. Kuo, O. Fiehn, S. Shahbaz, and L. Van Winkle Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E -/- mice Arterioscler Thromb Vasc Biol 31 2011 1260 1267